Healthcare
Friday, April 15, 2016
BRIEF-PTC Therapeutics says NICE recommends Translarna for treatment of patients with nonsense mutation duchenne muscular dystrophy in England
* National institute for health and care excellence
recommended translarna for ambulatory patients with nonsense
mutation duchenne muscular dystrophy
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment